Is this presentation consistent with inflammatory bowel disease (IBD) or another condition?

Is This IBD or Something Else?

The diagnosis of IBD requires a combination of clinical symptoms, laboratory biomarkers (especially fecal calprotectin), ileocolonoscopy with biopsies, and cross-sectional imaging—you cannot diagnose or exclude IBD based on symptoms alone. 1

Diagnostic Algorithm for Suspected IBD

Step 1: Assess Clinical Presentation and Red Flags

Look for these specific symptom patterns:

Crohn's Disease typically presents with:

• Abdominal pain (80%) and fatigue (81%)
• Diarrhea that may or may not be bloody
• Weight loss, fever
• Perianal disease 2

Ulcerative Colitis typically presents with:

• Bloody bowel movements (87%)
• Loose/watery diarrhea (87%)
• Urgent bowel movements (83%)
• Mucus passage (68%)
• Anxiety about bathroom distance (59%) 2

Critical distinction: If the patient has bloody diarrhea and urgency, UC is more likely; if they have abdominal pain without prominent bleeding, consider CD 2.

Step 2: Order Fecal Calprotectin First

Fecal calprotectin is your most sensitive screening tool with 88% sensitivity and 92% specificity for IBD at cutoff ≤50 μg/g 1. This biomarker:

• Distinguishes IBD from IBS better than any other test
• Correlates better with endoscopic activity than CRP
• Works better in UC than CD for detecting disease activity 1

A normal fecal calprotectin (<50 μg/g) makes IBD unlikely but doesn't completely exclude mild disease 1.

Step 3: Perform Ileocolonoscopy with Biopsies

This is the cornerstone diagnostic test and must be done unless contraindicated 1, 3. You need:

• Full colonoscopy with terminal ileum intubation
• Minimum of 2 biopsies from inflamed regions
• Additional biopsies from uninflamed regions and every colonic segment 3

Endoscopic findings that suggest Crohn's:

• Skip lesions, rectal sparing
• Terminal ileum involvement
• Aphthous ulcers, deep ulcers, serpiginous ulcers
• Cobblestoning 1

Endoscopic findings that suggest UC:

• Diffuse continuous inflammation starting from anal canal
• Granularity, loss of vascular pattern
• Friability, superficial ulcerations
• Sharp demarcation line between normal and abnormal mucosa 1

Step 4: Add Cross-Sectional Imaging

Combine colonoscopy with intestinal ultrasound (IUS), MR enterography (MRE), or both 1. This is particularly important because:

• IUS has 95% sensitivity and 77% specificity for CD
• Combined with Doppler, diagnostic accuracy approaches 95% for all bowel segments except rectum 1
• Detects complications and small bowel disease missed by colonoscopy

Step 5: If Colonoscopy and Imaging Are Negative

For suspected Crohn's with negative colonoscopy and imaging, proceed to capsule endoscopy of the small bowel 1.

Common Pitfalls and IBD Mimics

Do not assume treatment failure means refractory IBD—consider these mimics first 4:

• Infections: Viral, bacterial (C. difficile, CMV), mycobacterial, fungal, parasitic
• Vascular causes: Ischemic colitis
• Other immune conditions: Microscopic colitis, eosinophilic colitis
• Segmental colitis associated with diverticulitis (SCAD)
• Drug-induced colitis
• Small intestinal bacterial overgrowth (SIBO)
• Bile acid malabsorption

Special consideration: In patients with apparent IBD remission who have persistent IBS-like symptoms (post-IBD IBS-D), this may represent subclinical inflammation, coexisting IBS, or eosinophilic colopathy rather than treatment failure 5.

Critical warning: IBS and early UC share overlapping symptoms. If a patient initially diagnosed with IBS worsens despite treatment, you must pursue endoscopy and laboratory evaluation—do not continue symptomatic treatment alone 6.

Histologic Confirmation Requirements

For Crohn's disease diagnosis on biopsy:

• Granulomas plus one other feature, OR
• At least 3 features: segmental crypt architectural abnormalities, mucin preservation at active sites, focal chronic inflammation without crypt atrophy 3

For UC diagnosis on biopsy:

• Basal plasmacytosis (earliest feature, 38% within 2 weeks)
• Crypt architectural distortion (appears after 4 weeks)
• Mucosal atrophy, villous surface changes 3

Important caveat: In very early disease (<2 weeks), crypt architecture may be preserved, making distinction from infectious colitis difficult 3. The patchy inflammation pattern is only diagnostic in untreated adult patients 3.